Impact of chronic stress on the development of breast cancer

doi:10.16352/j.issn.1001-6325.2024.09.1303

Abstract

Abstract: Breast cancer is one of the most common cancers of females and is a leading cause of tumor-related death in women. Negative emotion frequently presents in patients like anxiety and depression and chronic stress which may lead to depression is a major risk factor of the cancer development. Stress leads to dysfunctions of cells, molecules and neural circuits, thus promoting depression. Chronic stress promotes the occurrence and development of breast cancer through related neurotransmitters and also affects the prognosis of breast cancer patients.

Key words: breast cancer, chronic stress, pathogenesis

CLC Number:

R737

SU Lingfeng, WANG Huxia, WANG Yanfeng, SONG Zhangjun. Impact of chronic stress on the development of breast cancer[J]. Basic & Clinical Medicine, 2024, 44(9): 1303-1307.

References 23

[1]	Kashyap D, Pal D, Sharma R, et al. Global increase in breast cancer incidence: risk factors and preventive measures[J]. Biomed Res Int, 2022,18. doi: 10.1155/2022/9605439.
[2]	Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and Meta-analysis of cohort studies[J]. Mol Psychiatry, 2020,25:1487-1499.
[3]	Wang X, Wang N, Zhong L,et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and Meta-analysis of 282,203 patients[J]. Mol Psychiatry, 2020,25:3186-3197.
[4]	Ye L, Hou Y, Hu W,et al. Repressed Blautia-acetate immunological axis underlies breast cancer progression promoted by chronic stress[J]. Nat. Commun, 2023,14. doi: 10.1038/s41467-023-41817-2.
[5]	Zhu Y, Wang A, Zhang S,et al. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells[J]. J Adv Res, 2023,49:159-173.
[6]	Sousa DM, Fernandes V, Lourenço C, et al. Profiling the adrenergic system in breast cancer and the development of metastasis[J].Cancers,2022,14.doi: 10.3390/cancers14225518.
[7]	Chi M, Shi X, Huo X,et al. Dexmedetomidine promotes breast cancer cell migration through Rab11-mediated secretion of exosomal TMPRSS2[J]. Ann Transl Med, 2020,8. doi: 10.21037/atm.2020.04.28.
[8]	Zhou Z, Cao Y, Yang Y,et al. METTL3-mediated m6 A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis[J]. Epigenetics, 2023,18. doi: 10.1080/15592294.2023.2217033.
[9]	Cui B, Peng F, Lu J,et al. Cancer and stress: NextGen strategies[J]. Brain Behav Immun, 2021,93:368-383.
[10]	Cui B, Luo Y, Tian P,et al. Stress-induced epinephrine enhances lactate dehydrogenase a and promotes breast cancer stem-like cells[J]. J Clin Invest, 2019,129:1030-1046.
[11]	Qu J, Li J, Zhang Y,et al. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway[J]. Cell Biosci, 2021,11. doi: 10.1186/s13578-021-00677-3.
[12]	Le CP, Nowell CJ, Kim-Fuchs C, et al. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination[J]. Nat Commun, 2016,7. doi: 10.1038/ncomms10634.
[13]	Lerner TN, Holloway AL, Seiler JL. Dopamine, updated: reward prediction error and beyond[J]. Curr Opin Neurobiol, 2021,67:123-130.
[14]	Strell C, Niggemann B, Voss MJ, et al. Norepinephrine promotes the β1-integrin-mediated adhesion of MDA-MB-231 cells to vascular endothelium by the induction of a GROα release[J]. Mol Cancer res, 2012,10:197-207.
[15]	Sai B, Dai Y, Fan S,et al. Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs[J]. Cell Death Dis, 2019,10:913-941.
[16]	Liu Z, Demian W, Persaud A,et al. Regulation of the p38-MAPK pathway by hyperosmolarity and by WNK kinases[J]. Sci Rep, 2022,12. doi: 10.1038/s41598-022-18630-w.
[17]	Zhou J, Liu Z, Zhang L,et al. Activation of β2-adrenergic receptor promotes growth and angiogenesis in breast cancer by down-regulating PPARγ[J].Cancer Res Treat, 2020,52:830-847.
[18]	De Deurwaerdère P, Di Giovanni G.Serotonin in health and disease[J]. Iin J Nt J Mol Sci, 2020,21:3500. doi: 10.3390/ijms21103500.
[19]	Gwynne WD, Shakeel MS, Girgis-Gabardo A, et al. The role of serotonin in breast cancer stem cells[J]. Molecules, 2021,26. doi: 10.3390/molecules26113171.
[20]	Wei B, Zhu Y, Yang P,et al. GABAB1e promotes the malignancy of human cancer cells by targeting the tyrosine phosphatase PTPN12[J].Iscience,2021,24.doi: 10.1016/j.isci.2021.103311.
[21]	Liao YC, Cheng TC, Tu SH,et al. Tumor targeting and therapeutic assessments of RNA nanoparticles carrying α9-nAChR aptamer and anti-miR-21 in triple-negative breast cancers[J]. Mol Ther Nucleic Acids, 2023,15:351-366.
[22]	Śliwińska-Mossoń M, Borowiecka K, Milnerowicz H. et al. Neuropeptides Y, YY, PP and their clinical significance[J]. Postepy Hig Med Dosw (Online), 2013,67:631-636.
[23]	Lei F, Vanderpool RC, McLouth LE,et al. Influence of depression on breast cancer treatment and survival: a Kentucky population-based study[J]. Cancer, 2023,129:1821-1835.